BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hsu MC, Weber CN, Stavropoulos SW, Clark TW, Trerotola SO, Shlansky-Goldberg RD, Soulen MC, Nadolski GJ. Passive expansion of sub-maximally dilated transjugular intrahepatic portosystemic shunts and assessment of clinical outcomes. World J Hepatol 2017; 9(12): 603-612 [PMID: 28515846 DOI: 10.4254/wjh.v9.i12.603]
URL: https://www.wjgnet.com/1948-5182/full/v9/i12/603.htm
Number Citing Articles
1
Marie-Louise Kloster, Albert Ren, Ketan Y. Shah, Murad M. Alqadi, James T. Bui, Andrew J. Lipnik, Matthew M. Niemeyer, Charles E. Ray, Ron C. Gaba. High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt CreationDigestive Diseases and Sciences 2020;  doi: 10.1007/s10620-020-06716-2
2
Dan Zheng, Jiao Yu, Hui Li, Hongying Gan, Jun Wang, Ting Jiang, Huanping Ren, Fan Wu. Effects of transjugular intrahepatic portosystemic shunt treatment of patients with liver cirrhosis and portal hypertensionMedicine 2021; 100(27): e26610 doi: 10.1097/MD.0000000000026610
3
Jonel Trebicka, Diana Bastgen, Jonathan Byrtus, Michael Praktiknjo, Sophia Terstiegen, Carsten Meyer, Daniel Thomas, Rolf Fimmers, Markus Treitl, Wulf Euringer, Tilman Sauerbruch, Martin Rössle. Smaller-Diameter Covered Transjugular Intrahepatic Portosystemic Shunt Stents Are Associated With Increased SurvivalClinical Gastroenterology and Hepatology 2019; 17(13): 2793 doi: 10.1016/j.cgh.2019.03.042